Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Shares Issued (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Shares Issued for 10 consecutive years, with $102.0 as the latest value for Q2 2025.

  • Quarterly Shares Issued changed N/A to $102.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $5000.0 for FY2025, 7.37% down from the prior year.
  • Shares Issued for Q2 2025 was $102.0 at Crescent Biopharma, down from $4898.0 in the prior quarter.
  • The five-year high for Shares Issued was $28.7 million in Q2 2023, with the low at -$28.6 million in Q3 2023.
  • Average Shares Issued over 4 years is $3.2 million, with a median of $4898.0 recorded in 2024.
  • Peak annual rise in Shares Issued hit 170198.7% in 2021, while the deepest fall reached 5289.95% in 2021.
  • Over 4 years, Shares Issued stood at -$9.5 million in 2021, then soared by 399.87% to $28.6 million in 2023, then crashed by 99.98% to $4898.0 in 2024, then tumbled by 97.92% to $102.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $102.0, $4898.0, and $28.6 million for Q2 2025, Q1 2024, and Q4 2023 respectively.